There are emerging evidence of non-pharmacologic therapeutics for psychiatric illnesses to modulate brain activity, often referred to as “neuromodulation”, which is a broad term that could technically be considered to cover any medical, surgical, or physiologic therapy designed to alter the function of the nervous system in some manner. In the clinical neurosciences, however, neuromodulation is understood to refer specifically to therapies that involve targeted delivery of electrical current or magneic field, which includes electroconvulsive therapy (ECT), one of the oldest treatments in psychiatry, and Vagus Nerve Stimulation (VNS), approved by the FDA in 2005 for severe depression, and repetitive Transcranial Magnetic Stimulation (rTMS), approved by the FDA in 2008 for the treatment of major depression. Recently, the studies using transcranial direct current stimulation (tDCS), vagal nerve stimulation (VNS), trigeminal nerve stimulation (TNS) and deep brain stimulation (DBS) have been also reported in a growing trend. To develop more effective treatments for psychiatric diseases, translational approaches bridging basic and clinical evidence deserves considerations.
In this Research Topic, we will provide a forum for researchers interested in basic, translational and clinical research of neuromodulation for psychiatric illnesses and aim to facilitate an integrative view of neuromodulation, to foster discussion across disciplines, and to stimulate collaboration.
There are emerging evidence of non-pharmacologic therapeutics for psychiatric illnesses to modulate brain activity, often referred to as “neuromodulation”, which is a broad term that could technically be considered to cover any medical, surgical, or physiologic therapy designed to alter the function of the nervous system in some manner. In the clinical neurosciences, however, neuromodulation is understood to refer specifically to therapies that involve targeted delivery of electrical current or magneic field, which includes electroconvulsive therapy (ECT), one of the oldest treatments in psychiatry, and Vagus Nerve Stimulation (VNS), approved by the FDA in 2005 for severe depression, and repetitive Transcranial Magnetic Stimulation (rTMS), approved by the FDA in 2008 for the treatment of major depression. Recently, the studies using transcranial direct current stimulation (tDCS), vagal nerve stimulation (VNS), trigeminal nerve stimulation (TNS) and deep brain stimulation (DBS) have been also reported in a growing trend. To develop more effective treatments for psychiatric diseases, translational approaches bridging basic and clinical evidence deserves considerations.
In this Research Topic, we will provide a forum for researchers interested in basic, translational and clinical research of neuromodulation for psychiatric illnesses and aim to facilitate an integrative view of neuromodulation, to foster discussion across disciplines, and to stimulate collaboration.